plk1 inhibitors (Institute for Research in Immunology and Cancer)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameplk1 inhibitors (Institute for Research in Immunology and Cancer)
Drug Alias Namepolo kinase inhibitors (Institute for Research in Immunology and Cancer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolo like kinase 1 inhibitors
TargetsPolo like kinase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInstitute For Research In Immunology And Cancer
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIRICoRInstitute For Research In Immunology And Cancer
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A